The global markets of L-Arginine have recorded a marginal uptrend in most of October 2025. The downstream demand from pharmaceutical and nutraceutical formulators have firmed their purchases and prompted replenishment after a subdued September. The Arginine buyers who ran down inventories in September and early October have created tightness in coverage which resulted in restocking. The stable production runs and an uninterrupted value chain have limited the scale of the rise. The plentiful feedstock (corn starch) have kept the input-cost inflation at bay and the prices increased by margins. The strategic prices from the Arginine suppliers, planned procurement for upcoming production cycles and inventory left from previous cycles have shaped a cautious market tone through the month. The combination of these factors have resulted in steady buyer activity which was sufficient to push prices upward but not enough to generate sharp spikes. ChemAnalyst after assessing the various market driving factors expects that the Arginine prices will trend slightly higher in upcoming period. The stakeholders should track feedstock markets and logistics indicators as secondary checks on upstream pressure.
